How Chinese Firms Are Saving Western Brands

How Chinese Firms Are Saving Western Brands

When U.S. home appliance brand SharkNinja was acquired by China’s Joyoung, observers may have expected a familiar story: cultural clashes, diluted brand identity, and eventual decline. Instead, SharkNinja accelerated its innovation cycle, adapted products more precisely to local markets such as Japan and the UK, and overtook long‑established competitors. Similar surprises followed when Chinese firms acquired century‑old…

Read More
Turn Privacy Regulation into a Competitive Advantage

Turn Privacy Regulation into a Competitive Advantage

When a new privacy regulation is announced, the reaction inside most companies is swift and familiar. Legal teams assess exposure, finance teams revise forecasts, and executives prepare for disruption. The market response follows quickly, with stock prices dipping and analysts highlighting rising costs. For many leaders, these early signals feel definitive, reinforcing the belief that…

Read More
How Lenovo Built an AI-Powered Supply Chain

How Lenovo Built an AI-Powered Supply Chain

Most companies deploying AI in their supply chains are making a common mistake: They are starting with the technology before understanding their data. They launch pilots, experiment with forecasting tools, and deploy isolated optimization engines—then wonder why almost none of it scales. The problem isn’t the AI. It’s that they skipped the step that makes…

Read More
AI’s Impact on SaaS Will Be Uneven. Here’s What Leaders Need to Know.

AI’s Impact on SaaS Will Be Uneven. Here’s What Leaders Need to Know.

For two decades, software-as-a-service (SaaS) grew by digitizing workflows. Customer relationship management systems recorded sales activity. Field-service platforms scheduled jobs, retrieved customer histories, and fed upsell opportunities back into sales teams. The model created value by taking opaque or messy information and putting it in workers’ hands. Before AI coding tools, few buyers were positioned…

Read More
Eli Lilly to Buy 3 Vaccine Developers

Eli Lilly to Buy 3 Vaccine Developers

Eli Lilly said on Tuesday that it would buy three vaccine developers in deals collectively worth up to $4 billion, a move that signals a return to an area that had not been a major focus for the company in recent years. The three are Curevo, a Seattle-area company developing a vaccine against shingles; LimmaTech…

Read More